Cabaletta Bio Inc
For the period ended Dec 31, 2023. Filed Mar 21, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 21, 2024
CABA$1.45-3.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets as of December 31, 2023 and 2022
Balance Sheets
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $193,238 | $81,607 |
| Short-term investments | 48,011 | 24,940 |
| Prepaid expenses and other current assets | 3,241 | 2,287 |
| Total current assets | 244,490 | 108,834 |
| Property and equipment, net | 2,541 | 2,578 |
| Operating lease right-of-use assets | 4,910 | 4,991 |
| Other assets | 1,709 | 565 |
| Total Assets | $253,650 | $116,968 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $4,547 | $2,463 |
| Accrued and other current liabilities | 7,887 | 4,847 |
| Operating lease liabilities, current portion | 3,560 | 2,179 |
| Total current liabilities | 15,994 | 9,489 |
| Operating lease liabilities, net of current portion | 1,458 | 2,959 |
| Total Liabilities | 17,452 | 12,448 |
| Commitments and contingencies (see Notes 6 and 7) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.00001 par value: 10,000,000 shares authorized as of December 31, 2023 and 2022; no shares issued or outstanding at December 31, 2023 or 2022 | — | — |
| Voting and non-voting common stock, $0.00001 par value: 150,000,000 (143,590,481 voting and 6,409,519 non-voting) shares authorized as of December 31, 2023 and December 31, 2022; 47,823,232 (46,378,937 voting and 1,444,295 non-voting) shares issued and outstanding as of December 31, 2023 and 29,445,134 (27,584,375 voting and 1,860,759 non-voting) shares issued and outstanding as of December 31, 2022 | — | — |
| Additional paid-in capital | 469,396 | 270,129 |
| Accumulated other comprehensive income (loss) | 39 | (47) |
| Accumulated deficit | (233,237) | (165,562) |
| Total stockholders’ equity | 236,198 | 104,520 |
| Total liabilities and stockholders’ equity | $253,650 | $116,968 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.